Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Cosmetic – antiperspirant – dentifrice
Reexamination Certificate
2005-01-18
2005-01-18
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Cosmetic, antiperspirant, dentifrice
C514S057000, C514S535000, C560S043000, C560S044000, C560S045000, C560S046000, C536S032000
Reexamination Certificate
active
06844003
ABSTRACT:
The invention relates to novel compounds of formula (I) wherein R1represents a polymer, aryl or alkyl group, R2presents a hydrogen atom, a halogen atom, a radical CN, CF3, OH, OCF3, COOH, R7, OR7or OCOR7, R3represents an aryl or alkyl halogen, R4represents an alkyl radical. The invention also relates to a cosmetic composition comprising said compounds and to the use thereof to reduce and/or curb hair loss i.e. to increase and/or stimulate the growth of said hair
REFERENCES:
patent: 4139619 (1979-02-01), Chidsey, III
patent: 4278790 (1981-07-01), McCormick
patent: 4596812 (1986-06-01), Chidsey, III et al.
patent: 4767750 (1988-08-01), Jacquet et al.
patent: 4973474 (1990-11-01), Hocquaux et al.
patent: 5053228 (1991-10-01), Mori et al.
patent: 5132106 (1992-07-01), Tuloup et al.
patent: 5438058 (1995-08-01), Dufetel et al.
patent: 5466694 (1995-11-01), Terranova et al.
patent: 5760043 (1998-06-01), Dufetel et al.
patent: 5772990 (1998-06-01), Hocquaux et al.
patent: 6455691 (2002-09-01), Hlynianski
patent: 0 353 123 (1990-01-01), None
patent: 0 356 271 (1990-02-01), None
patent: 0 408 442 (1991-01-01), None
patent: 0 420 707 (1991-04-01), None
patent: 0 459 890 (1991-12-01), None
patent: 0 519 819 (1992-12-01), None
patent: 0 522 964 (1993-01-01), None
patent: 0 648 488 (1995-04-01), None
patent: 2 581 542 (1986-11-01), None
patent: 52-128329 (1977-10-01), None
patent: WO 9422468 (1994-10-01), None
patent: WO 9732562 (1997-09-01), None
McCormick, “Solution Studies of Cellulose in Lithium Chloride and N,N-Dimethylacetamide” Macromolecules, vol. 18, pp. 2394-2401 (1985).*
English language Derwent Abstract of EP 0 648 488, Apr. 19, 1995.
Webster's II New Riverside Dictionary. Houghton Mifflin Co., 1994, p. 316.
Bebernitz et al., “Anilides of (R)-Trifluoro-2-hydroxy-2-methylpropionic Acid as Inhibitors of Pyruvate Dehydrogenase Kinase,” Journal of Medicinal Chemistry, vol. 43, 2000, pp. 2248-2257.
English Abstract of JP 52-128329 (Mori et al.) Derwent Information, Ltd., 1999.
“N,N-Dimethylacetamide (DMAC)” Technical Leaflet, BASF, 2001.
Frank D. King, “Bioisosteres, Conformational Restriction, and Pro-drugs—Case History: An Example of a Conformational Restriction Approach,” Medicinal Chemistry: Principles and Practice, Chapter 14, 1994, pp. 206-225.
Thomas D. Aicher, “(R)-3,3,3-Trifluoro-2-hydroxy-2-methyl-propionamides Are Orally Active Inhibitors of Pyruvate Dehydrogenase Kinase,” Journal of Medicinal Chemistry, vol. 42, No. 15, Jul. 1999, pp. 2741-2746.
English language Derwent Abstract of EP 0 353 123, Jan. 31, 1990.
Breton Lionel
Dalko Maria
Galey Jean-Baptiste
"L'Oreal"
Finnegan Henderson Farabow Garrett & Dunner LLP
Raymond Richard L.
Tucker Zachary C.
LandOfFree
Compounds derived from benzoic acid esters, composition... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds derived from benzoic acid esters, composition..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds derived from benzoic acid esters, composition... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3393704